Emtricitabine is an antiretroviral medication primarily used in the treatment of HIV infection. It belongs to the class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). The chemical formula for emtricitabine is C₁₃H₁₅N₃O₃S, and it features a thiophene ring, which contributes to its unique properties. Emtricitabine is characterized by its ability to inhibit the reverse transcriptase enzyme, thereby preventing the replication of the virus. It is typically administered orally and is well-absorbed in the gastrointestinal tract. The drug is known for its favorable pharmacokinetic profile, including a long half-life, which allows for once-daily dosing. Emtricitabine is often used in combination with other antiretroviral agents to enhance efficacy and reduce the risk of resistance. Common side effects may include gastrointestinal disturbances and skin rashes, but it is generally well-tolerated. Its effectiveness and safety profile have made it a key component in HIV treatment regimens worldwide.

emtricitabine

143491-57-0: (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine, (-)-2'-Deoxy-5-fluoro-3'-thiacytidine, (-)-2′,3′-Dideoxy-5-fluoro-3′-thiacytidine, (-)-Beta-2',3'-Dideoxy-5-Fluoro-3'-Thiacytidine, (-)-Ftc, 1,3-Oxathiolane, 2(1H)-pyrimidinone deriv., 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-5-oxathiolanyl]-, 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2R-cis)-, 4-Amino-5-Fluoro-1-(2-(Hydroxymethyl)-1,3-Oxathiolan-5-Yl)-(2R-Cis)-2(1H)-Pyrimidinone, 4-Amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone, 4-amino-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one, 524W91, Bw 1592, Bw 524W91, Coviracil, Emitricibatine, Emitricitabine, Emtricitabin, Emtritabine, Emtriva, Fumitremorgin C, Sm-Q

CAS 143491-57-0: emtricitabine

Emtricitabine

Ref: 7W-GP7326

Emtricitabine

Ref: TR-MM1325.00